Bioscience

Holland & Hart lawyers have represented major bioscience companies throughout the United States and have experience in virtually every aspect of the lifespan of the bioscience company. From initial start-up stages relating to corporate formation, organization and financing, to the assessment, acquisition, and enforcement of intellectual property rights relating to complex technologies, our attorneys have the relevant experience to assist bioscience companies overcome an array of legal challenges.

Intellectual Property Prosecution

Holland & Hart's patent prosecution attorneys regularly obtain and enforce patents in many areas of bioscience. With technical knowledge in a wide range of scientific disciplines, including biofuels, biomaterials, biomedical devices, biochemistry, genetics, molecular biology, and biotechnology, our attorneys have successfully represented clients in patent acquisition in the United States and foreign patent offices on matters involving patent preparation, prosecution, appeals, interferences, reexaminations, reissues, and oppositions.

Technology Licensing

Holland & Hart attorneys are experienced in structuring, negotiating, and drafting technology agreements, including technology licenses, joint research agreements, contract research agreements, complex strategic partnership and joint venture agreements, commercial supply agreements, clinical trials agreements, co-marketing agreements, and complex international commercial transactions.

Litigation

Our trial attorneys work with virtually all aspects of litigation, including general commercial litigation and intellectual property and patent litigation.

Corporate Counseling

Holland & Hart attorneys are advisors and negotiators in matters relevant to emerging growth companies, including matters relating to incorporation, corporate securities, stock option plans, employee compensation, board resolutions, real estate, and employment. Our attorneys also advise clients on the legal and business issues relating to public and private financings, and mergers.